Bound Brook, NJ (October 22, 2015) DZS Software Solutions, Inc. today announced the release of ClinPlus CTMS version 2.3, a Clinical Trial Management System (CTMS) that includes 70 enhancements, most of which were inspired by customer feedback.
“Because DZS Software Solutions, Inc. is a customer focused company, their requests were given serious consideration and are the driving force behind Version 2.3,” said Bob Borysko, Vice President of Business Development. “As new clients come online they invariably will have unique requirements they would like to see addressed in the software. Our software engineers evaluate each request and design solutions that will not only satisfy the client making the request, but also may benefit the entire user base and improve overall marketability. This customer focused design philosophy is the primary reason for our high level of customer satisfaction and accelerating rate of new client adoption.”
Version 2.3 adds the ability to support read-only licenses and every ClinPlus CTMS client will receive five at no additional cost. Other areas of improvements include:
The development process continues toward the next major release for 2016, ClinPlus eClinical 3, which will not only include significant enhancement to CTMS but will also incorporate full EDC capabilities within the eClinical platform. To learn more, contact Bob Borysko at (732) 764-6969.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.